Data as of Mar 07
| +0.05 / +1.51%|
The 1 analysts offering 12-month price forecasts for Aastrom Biosciences Inc have a median target of 4.50, with a high estimate of 4.50 and a low estimate of 4.50. The median estimate represents a +33.93% increase from the last price of 3.36.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.